TITLE

NATURE OF THE EVIDENCE BASE FOR EVIDENCE-BASED MENTAL HEALTH CARE

AUTHOR(S)
Schloss, Heather M.; Haaga, David A. F.
PUB. DATE
September 2005
SOURCE
Journal of Cognitive & Behavioral Psychotherapies;Sep2005, Vol. 5 Issue 2, p207
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the nature of the evidence base for evidence-based mental health care in the U.S. Concerns raised on the decision of psychotherapists regarding a treatment strategy; Forms of evidence related to the choice of treatment strategies, including the outcomes of randomized clinical trials; Existence of controversy concerning the efforts to promote use of and training in empirically supported treatments; Information on change studies.
ACCESSION #
18487285

 

Related Articles

  • Developing Effective Research-Practice Partnerships for Creating a Culture of Evidence-Based Decision Making. Riemer, Manuel; Kelley, Susan; Casey, Susan; Taylor Haynes, Katherine // Administration & Policy in Mental Health & Mental Health Service;Jul2012, Vol. 39 Issue 4, p248 

    With growing evidence that treatment as usual may have limited effectiveness in mental health the pressure on service providers to be accountable and produce evidence as to the effectiveness of their services has increased. Measurement Feedback Systems, such as the Contextualized Feedback System...

  • Beware of Over-Interpreting Negative Trials. Scahill, Lawrence; Aman, Michael G.; McCracken, James T.; McDougle, Christopher J.; Vitiello, Benedetto // Journal of Autism & Developmental Disorders;Oct2008, Vol. 38 Issue 9, p1609 

    The article focuses on the pragmatic trial which addresses a problem of clinical decision-making. In its pure form, a pragmatic trial would compare two evidence-based treatments to help clinicians in selecting which one should be selected first. By contrast, an efficacy trial is designed to...

  • LETTERS. Ludewig, Kurt; Duncan, Barry; Miller, Scott; Lebow, Jay; Wilder, David // Psychotherapy Networker Magazine;Jul/Aug2007, Vol. 31 Issue 4, p11 

    Several letters to the editor are presented in response to articles in previous issues including "Defining Psychotherapy," by Jay Efran and colleagues in the March/April 2007 issue, "A Look at the Evidence," by Jay Lebow in the March/April 2007 issue, and "The Top 10: The Most Influential...

  • Technology transfer for the implementation of a clinical trials network on drug abuse and mental health treatment in Mexico. Horigian, Viviana E.; Marín-Navarrete, Rodrigo A.; Verdeja, Rosa E.; Alonso, Elizabeth; Perez, María A.; Fernández-Mondragón, José; Berlanga, Carlos; Medina-Mora, María Elena; Szapocznik, José // Pan American Journal of Public Health;2015, Vol. 38 Issue 3, p233 

    Low- and middle-income countries (LMIC) lack the research infrastructure and capacity to conduct rigorous substance abuse and mental health effectiveness clinical trials to guide clinical practice. A partnership between the Florida Node Alliance of the United States National Drug Abuse Treatment...

  • Illinois breaks ground on evidence-based practice initiative.  // Getting Paid in Behavioral Healthcare;Feb2003, Vol. 8 Issue 2, p4 

    Reports on the groundwork being laid by Illinois officials for the development and use of more evidence-based practice in the state's public mental health system. Details of the document released by the Illinois Department of Human Services; Composition of Illinois' public mental health system;...

  • Biological Drugs for the Treatment of Moderate-to-Severe Psoriasis by Subcutaneous Route: Determining Statistical Equivalence According to Evidence-Based Methods. Messori, Andrea; Fadda, Valeria; Maratea, Dario; Trippoli, Sabrina; Gatto, Roberta; Rosa, Mauro; Marinai, Claudio // Clinical Drug Investigation;Aug2014, Vol. 34 Issue 8, p593 

    Background: Although several evidence-based analyses have found that in patients with moderate-to-severe psoriasis, biological agents for subcutaneous use show no difference in efficacy (no proof of difference), there is limited evidence on whether or not there is also proof of no difference....

  • Process steps and suggestions for creating drug monographs and drug class reviews in an evidence-based formulary system. Strite, Sheri A.; Stuart, Michael E.; Urban, Shaun // Formulary;Apr2008, Vol. 43 Issue 4, p135 

    Given the high estimates of inappropriate healthcare decisions in this country and the well-documented evidence of inappropriate variations in healthcare, a well-functioning formulary system is of great importance. Bias in research tends to inflate or falsely report benefit in clinical trials of...

  • Your turn to learn to read: Evaluating articles about treatment in the medical literature. Christakis, Dimitri A. // Contemporary Pediatrics;May2003, Vol. 20 Issue 5, p79 

    Discusses a comprehensive way of evaluating any published study that addresses a treatment for a disease or condition in order to help physicians who practice evidence-based medicine apply the findings to the care of patients. Benefits of considering a research that used the randomized method...

  • Evidence-Based Medicine Case Studies.  // Health Affairs;Jan/Feb2005, Vol. 24 Issue 1, p41 

    This article focuses on evidence-based medicine. Clinical trials for evidence-based medicine (EBM) can stop traditional therapies dead in their tracks; likewise, they can introduce new drugs and procedures to medical practice. Findings from previous studies have spurred the EBM community to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics